CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer
British Journal of Biomedical Science · 2023
DOI: 10.3389/bjbs.2023.11103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Biomedical Science, 2023. Verfasst von Xiew Leng Liau und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, International Medical University, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Colorectal Neoplasms, MicroRNAs, Colonic Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is ranked as the third most common cancer and second deadliest cancer in both men and women in the world. Currently, the cure rate and 5-year survival rate of CRC patients remain relatively low. Therefore, discovering a novel molecular biomarker that can be used to improve CRC screening, diagnosis, prognosis, and treatment would be beneficial. Long non-coding RNA colon cancer-associated transcript 1 (CCAT 1) has been found overexpressed in CRC and is associated with CRC tumorigenesis and treatment outcome. CCAT 1 has a high degree of specificity and sensitivity, it is readily detected in CRC tissues and is significantly overexpressed in both premalignant and malignant CRC tissues. Besides, CCAT 1 is associated with clinical manifestation and advanced features of CRC, such as lymph node metastasis, high tumor node metastasis stage, differentiation, invasion, and distant metastasis. In addition, they can upregulate oncogenic c-MYC and negatively modulate microRNAs via different mechanisms of action. Furthermore, dysregulated CCAT 1 also enhances the chemoresistance in CRC cells while downregulation of them reverses the malignant phenotypes of cancer cells. In brief, CCAT 1 serves as a potential screening, diagnostic and prognostic biomarker in CRC, it also serves as a potential therapeutic marker to treat CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, International Medical University, Kuala Lumpur, Malaysia.
- Department of Biotechnology, Faculty of Applied Sciences, UCSI University, Kuala Lumpur, Malaysia.
- Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
- Department of Pathology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
Zitieren
APA
Liau, X. L., Salvamani, S., Gunasekaran, B., Chellappan, D. K., Rhodes, A., Ulaganathan, V., & Tiong, Y. L. (2023). CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer. British Journal of Biomedical Science. https://doi.org/10.3389/bjbs.2023.11103
Vancouver
Liau XL, Salvamani S, Gunasekaran B, Chellappan DK, Rhodes A, Ulaganathan V, et al. CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer. British Journal of Biomedical Science. 2023. doi:10.3389/bjbs.2023.11103
BibTeX
@article{Liau2023,
author = {Liau, Xiew Leng and Salvamani, Shamala and Gunasekaran, Baskaran and Chellappan, Dinesh Kumar and Rhodes, Anthony and Ulaganathan, Vaidehi and Tiong, Yee Lian},
title = {CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer},
journal = {British Journal of Biomedical Science},
year = {2023},
doi = {10.3389/bjbs.2023.11103}
}
EUVIMED